Nucelion Therapeutics Launches to Revolutionize Advanced Therapies
Published on: Nov. 3, 2025, 7:07 p.m. | Source: Devdiscourse
Nucelion Therapeutics, a subsidiary of Bharat Biotech, has started operations to support life science innovators with scalable and high-quality processes for advanced therapies targeting cancers, autoimmune, and rare genetic disorders. The company aims to integrate these therapies into India's healthcare ecosystem.
